1. Home
  2. BLLN vs TRMD Comparison

BLLN vs TRMD Comparison

Compare BLLN & TRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BLLN

BillionToOne Inc.

N/A

Current Price

$80.12

Market Cap

3.5B

Sector

Health Care

ML Signal

N/A

Logo TORM plc

TRMD

TORM plc

HOLD

Current Price

$26.54

Market Cap

2.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLLN
TRMD
Founded
2016
1889
Country
United States
United Kingdom
Employees
713
N/A
Industry
Medical Specialities
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
2.9B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
BLLN
TRMD
Price
$80.12
$26.54
Analyst Decision
Buy
Buy
Analyst Count
7
1
Target Price
$129.57
$34.00
AVG Volume (30 Days)
318.7K
1.0M
Earning Date
03-04-2026
05-07-2026
Dividend Yield
N/A
8.25%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$45.89
N/A
Revenue Next Year
$30.17
N/A
P/E Ratio
N/A
$9.61
Revenue Growth
N/A
N/A
52 Week Low
$61.96
$13.63
52 Week High
$138.70
$31.76

Technical Indicators

Market Signals
Indicator
BLLN
TRMD
Relative Strength Index (RSI) 54.69 50.55
Support Level $63.98 $21.54
Resistance Level $86.01 $31.76
Average True Range (ATR) 5.61 0.89
MACD 1.30 -0.35
Stochastic Oscillator 75.47 36.10

Price Performance

Historical Comparison
BLLN
TRMD

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About TRMD TORM plc

TORM plc operates as a shipping company mainly owning and operating a fleet of product tankers. It is engaged in the transportation of refined oil products and clean petroleum products, including gasoline, jet fuel, naphtha and diesel oil. The Company operates through two segments: the Tanker segment and the Marine Engineering segment, deriving the majority of its revenue from the Tanker segment.

Share on Social Networks: